<DOC>
	<DOC>NCT01863589</DOC>
	<brief_summary>This post-marketing surveillance (PMS) is conducted to collect safety and efficacy data among subjects with chronic hepatitis B and hepatic cirrhosis B who is treated with adefovir tablets.</brief_summary>
	<brief_title>Drug Use Investigation for HEPSERA (Adefovir) Tablet</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<criteria>Subjects with chronic hepatitis B or hepatic cirrhosis B Subjects treated with adefovir tablets</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>